Pakistan Covid Patient Assumption

Market Size 2020 2020 (Jul-Dec) 2021 2022

Total Population 200,813,816 200,813,816 204,830,092 208,926,694

COVID-19 Confirmed Cases 964,909 350,000 974,558 984,303
COVID-19 Confirmed Cases % 0.48% 0.50% 0.50% 0.50%
Mild/Asymptomatic cases 771,927 280,000 779,646 787,443
Mild/Asymptomatic cases % 80.00% 80.00% 80.00% 80.00%
Severe COVID-19 Patients (Requiring Oxygen) 144,736 52,500 146,184 147,646
Severe COVID-19 Patients (Requiring Oxygen)% 15.0% 15.0% 15.0% 15.0%
Critical Patients (Requiring Ventilation) 48,245 17,500 48,728 49,215
Critical Patients (Requiring Ventilation) % 5.0% 5.0% 5.0% 5.0%
Total Deaths 21,443 11,165 19,491 19,686
Total Deaths % 2.22% 3.19% 2.00% 2.00%
Total Ventilators in Pakistan 8,000 5,000 9,200 10,580
Total Ventilators reserved for COVID 6,000 3,000 5,520 5,290
Total Ventilators reserved for COVID% 75% 60% 60% 50%
COVID-19 Confirmed Cases 1% Percent increase in cases – Vaccine
easily available but strains of the virus is
changing

1,000,000 1% Percent increase in cases – 974,558 984,303

964,909
Although cases
considering development in treatment
options & Vaccine availability in 2021
are decreasing in
but changes in strains on the virus

Pakistan on a daily
800,000 basis - Included
Impact of Eid ul
Azha, Muharram,
600,000
Rabi ul awal &
increased testing
capacity

400,000
350,000

200,000
2020 2020 (Jul-Dec) 2021 2022
Docetaxel | An opportunity to cater to an unmet need
Strengths for ICI:
- Strong external equity in Critical Care segment
- Robust capability set to promote specialty products
- Account Development and Patient Acquisition Mindset
Challenges and Support Areas
- Price Sensitive Market
- No FDA Approval
Support needed for Access
- Patient Support Programs
COVID-19 Confirmed Cases

502,035 Assumptions
- Patient Potential
- TP

Mild/Asymptomatic cases (80%)

401,628
Severe COVID-19 Patients (Requiring Oxygen)(15%)
75,305

Critical Patients (Requiring

Ventilation)(5%)
25,102